Registration statement for securities of certain foreign private issuers

Equity (Details Textual)

v3.19.3.a.u2
Equity (Details Textual) - USD ($)
$ / shares in Units, $ in Thousands
 1 Months Ended 12 Months Ended
May 22, 2019
Mar. 13, 2018
Mar. 09, 2018
Apr. 04, 2019
Jan. 18, 2019
Mar. 31, 2018
Dec. 31, 2017
Jan. 31, 2017
Oct. 31, 2015
Sep. 30, 2015
Mar. 31, 2014
Nov. 28, 2013
Dec. 31, 2018
Dec. 31, 2016
Dec. 31, 2015
May 31, 2018
Dec. 03, 2015
Statement Line Items [Line Items]                                  
Ordinary shares 45,000,000     9,846,156 4,476,192                        
Gross proceeds $ 6,000     $ 3,200 $ 2,350                        
Series Ten [Member]                                  
Statement Line Items [Line Items]                                  
Fair value of warrants issued                           $ 146 $ 240    
Registered warrants                         39,042,000        
Warrants were exercisable into ordinary shares                         1,561,680        
Warrants expired date                         Oct. 31, 2017        
Series Ten [Member] | NIS [Member]                                  
Statement Line Items [Line Items]                                  
Warrants exercise price                         $ 9.85        
Series Eleven [Member]                                  
Statement Line Items [Line Items]                                  
Fair value of warrants issued                           126 307    
Registered warrants                         37,372,500        
Warrants were exercisable into ordinary shares                         1,494,900        
Warrants expired date                         Oct. 31, 2017        
Series Eleven [Member] | NIS [Member]                                  
Statement Line Items [Line Items]                                  
Warrants exercise price                         $ 9.80        
Series Twelve [Member]                                  
Statement Line Items [Line Items]                                  
Fair value of warrants issued                           $ 291 $ 303    
Registered warrants                         1,470,000        
Warrants were exercisable into ordinary shares                         1,470,000        
Warrants expired date                         Oct. 31, 2017        
Series Twelve [Member] | NIS [Member]                                  
Statement Line Items [Line Items]                                  
Warrants exercise price                         $ 15.29        
Series Seven [Member]                                  
Statement Line Items [Line Items]                                  
Registered warrants                     9,907,500            
Warrants were exercisable into ordinary shares                     396,300            
Financial income                     $ 258            
December 2014 Financing [Member]                                  
Statement Line Items [Line Items]                                  
Financing of commitment                     $ 1,535            
March 2014 Financing [Member]                                  
Statement Line Items [Line Items]                                  
Ordinary shares par value                     $ 2.225            
Fair value of warrants issued                     $ 1,098            
Two Zero One Three Paln [Member]                                  
Statement Line Items [Line Items]                                  
Description of option agreement                       Under the 2013 Plan, the Company may grant its officers, directors, employees and consultants, Stock options, of the Company. Each Stock option granted shall be exercisable at such times and terms and conditions as the Board of Directors may specify in the applicable option agreement, provided that no option will be granted with a term in excess of 10 years.          
Reserved for issuance shares of common stock                       2,500,000          
Options are exercisable into ordinary shares                         1,215,000        
Two Zero One Three Paln [Member] | NIS [Member]                                  
Statement Line Items [Line Items]                                  
Ordinary shares par value                       $ 0.25          
Wize Pharma Inc [Member]                                  
Statement Line Items [Line Items]                                  
Ordinary shares             356,803           356,803        
ADS [Member]                                  
Statement Line Items [Line Items]                                  
Ordinary shares             138,890                 400,000  
Additional ordinary shares             69,445                    
Ordinary shares issued                         18,500     200,000  
Warrants term               five and a half years                  
Warrants exercise price               $ 2.25                  
ADS [Member] | December 2014 Financing [Member]                                  
Statement Line Items [Line Items]                                  
Ordinary shares                     3.215            
Warrants exercise price                     $ 6.43            
ADS [Member] | March 2014 Financing [Member]                                  
Statement Line Items [Line Items]                                  
Warrants exercise price                     $ 4.45            
ADS [Member] | Placement Agent Warrants [Member]                                  
Statement Line Items [Line Items]                                  
Ordinary shares               250,000                  
Warrants to purchase shares issued               125,000                  
Warrants exercise price               $ 2.25                  
Ordinary Shares [Member]                                  
Statement Line Items [Line Items]                                  
Ordinary shares par value                           $ 0.25 $ 0.25    
Number of shares authorized             80,000,000           80,000,000 80,000,000      
Warrants to purchase additional shares   5,000,004                              
Aggregate purchase price   $ 5,000                              
Ordinary Shares [Member] | NIS [Member]                                  
Statement Line Items [Line Items]                                  
Ordinary shares par value                                 $ 0.25
Authorized share capital                                 $ 10,000
Increased authorized share capital                                 $ 20,000
Number of shares authorized                                 80,000,000
Ordinary Shares [Member] | ADS [Member]                                  
Statement Line Items [Line Items]                                  
Ordinary shares                         37,000        
March 2014 Financing [Member]                                  
Statement Line Items [Line Items]                                  
Ordinary shares     982,344                            
Warrants to purchase additional shares     98,234                            
January 2017 Financing [Member]                                  
Statement Line Items [Line Items]                                  
Fair value of warrants issued               $ 1,868                  
Cash issuance costs               $ 621                  
January 2017 Financing [Member] | ADS [Member]                                  
Statement Line Items [Line Items]                                  
Financing of commitment                         $ 1,868        
January 2017 Financing [Member] | ADS [Member] | Private Placement and Accredited Investors [Member]                                  
Statement Line Items [Line Items]                                  
Sold an aggregate shares   3,333,336           2,500,000                  
Ordinary shares   6,666,672           5,000,000                  
Warrants to purchase additional shares   2,500,002           1,250,000                  
Additional ordinary shares               2,500,000                  
Aggregate purchase price               $ 5,000                  
Description of warrants exercised   The warrants may be exercised after 6 months from the date of issuance for a period of five and a half years and have an exercise price of USD 2.00 per ADS (subject to certain adjustments). The Company also issued placement agent warrants to purchase 166,667 ADSs representing 333,334 ordinary shares exercisable at USD 2.00 per ADS, subject to certain adjustments, for a period of five years.                              
September 2015 Financing [Member]                                  
Statement Line Items [Line Items]                                  
Warrants to purchase shares issued                           2,275,863      
Fair value of warrants issued                         188        
Cash issuance costs                         $ 789        
September 2015 Financing [Member] | ADS [Member]                                  
Statement Line Items [Line Items]                                  
Warrants term                           Five years      
September 2015 Financing [Member] | ADS [Member] | Direct Offering [Member]                                  
Statement Line Items [Line Items]                                  
Ordinary shares                   2,068,966              
Additional ordinary shares                   2,068,966              
Gross proceeds                   $ 9,000              
Issued unregistered warrants to purchase                   1,034,483              
Ordinary shares issued                   4,137,932              
September 2015 Financing [Member] | ADS [Member] | Placement Agent Warrants [Member]                                  
Statement Line Items [Line Items]                                  
Warrants to purchase shares issued                         103,448        
Ordinary shares issued                         206,897        
Exercisable price per share                         $ 5.25        
Equivalent to ordinary share price per share                         $ 2.625        
Subject to certain adjustments, for a period                         5 years        
Cash issuance costs                         $ 317        
January 2018 Financing [Member]                                  
Statement Line Items [Line Items]                                  
Financing of commitment           $ 3,593                      
October 2015 Financing [Member]                                  
Statement Line Items [Line Items]                                  
Warrants to purchase shares issued                         998,276        
Cash issuance costs                         $ 525        
October 2015 Financing [Member] | ADS [Member]                                  
Statement Line Items [Line Items]                                  
Warrants term                           Half years      
October 2015 Financing [Member] | ADS [Member] | Direct Offering [Member]                                  
Statement Line Items [Line Items]                                  
Ordinary shares                 1,109,196                
Additional ordinary shares                 887,356                
Gross proceeds                 $ 4,825                
Issued unregistered warrants to purchase                 443,678                
Ordinary shares issued                 2,218,392                
October 2015 Financing [Member] | ADS [Member] | Placement Agent Warrants [Member]                                  
Statement Line Items [Line Items]                                  
Warrants to purchase shares issued                         55,460        
Ordinary shares issued                         110,920        
Exercisable price per share                         $ 5.25        
Equivalent to ordinary share price per share                         $ 2.625        
Subject to certain adjustments, for a period                         5 years        
Fair value of warrants issued                         $ 143        
September 2015 Financing and October 2015 Financing [Member]                                  
Statement Line Items [Line Items]                                  
Ordinary shares par value                         $ 2.625        
September 2015 Financing and October 2015 Financing [Member] | ADS [Member]                                  
Statement Line Items [Line Items]                                  
Fair value of warrants issued                         $ 3,167        
Warrants exercise price                         $ 5.25        
Financing of commitment                         $ 1,147